Register for our free email digests:
Division of Merck KGAA
Latest From BioReliance Corp.
A roundup of recent medtech mergers & acquisitions, strategic alliances, and financings.
The Dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.
- Contract Research, Toxicology Testing-CRO
- In Vitro Diagnostics
- Therapeutic Areas
- Microbiological Associates
- North America
- Parent & Subsidiaries
- Merck KGAA
- Senior Management
Charles Harwood, Pres. & CEO
David Onions, PhD, CSO
David L Bellitt, VP, Global Commercial Ops., Biologics
- Contact Info
Phone: (301) 738-1000
14920 Broschart Rd.
Rockville, MD 20850-3349
You must sign in to use this functionality
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.